ATC code M04 Antigout preparations is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3] Subgroup M04 is part of the anatomical group M Musculo-skeletal system.[4]

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QM04.[5]
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

M04A Antigout preparations

edit

M04AA Preparations inhibiting uric acid production

edit
M04AA01 Allopurinol
M04AA02 Tisopurine
M04AA03 Febuxostat
M04AA51 Allopurinol, combinations
M04AB01 Probenecid
M04AB02 Sulfinpyrazone
M04AB03 Benzbromarone
M04AB04 Isobromindione
M04AB05 Lesinurad

M04AC Preparations with no effect on uric acid metabolism

edit
M04AC01 Colchicine
M04AC02 Cinchophen
M04AC51 Colchicine and probenecid

M04AX Other antigout preparations

edit
M04AX01 Urate oxidase
M04AX02 Pegloticase

References

edit
  1. ^ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
  2. ^ World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
  3. ^ "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
  4. ^ "ATC/DDD Index 2022: code M04". WHO Collaborating Centre for Drug Statistics Methodology.
  5. ^ "ATCvet Index 2022: code QM04". WHO Collaborating Centre for Drug Statistics Methodology.